Romlusevimab
Product Specifications
CAS Number
2509447-08-7
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Purity
1
Bioactivity
Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx139797 100 Tests
Platelet Derived Growth Factor Receptor Alpha (PDGFRA) Antibody (PE)
Sign In for Pricing
View Details 
MBS629263-01 0.2 mL
Cdc25A, phosphorylated (Ser79) (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A)
Sign In for Pricing
View Details MBS629263-02 5x 0.2 mL
Cdc25A, phosphorylated (Ser79) (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A)
Sign In for Pricing
View Details